Adaptive Biotechnologies Corporation
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer …
Segment Analysis Beta
The financial segments are sourced from the SEC' 10-K statement.Revenue By Top Segments
Adaptive Biotechnologies Corporation can't present it's sankey chart.
Historical Revenue By Segment
Last 3Y, in million USDAdaptive Biotechnologies Corporation can't present revenue by segment
Get PRO Today
With PRO you can bypass the blur for the segment revenues of Adaptive Biotechnologies Corporation.
If you want to see a demo, head over to the financial segments of AAPL